Pharvaris B.V. (PHVS) PT Lowered at RBC Capital; 'CHAPTER-3 Pivotal Topline In Focus For 3Q'
RBC Capital analyst Nevin Varghese lowered the price target on Pharvaris B.V. (NASDAQ: PHVS) to $51.00 (from $52.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
